Nasal steam therapy for respiratory issues after thyroid surgery
Effectiveness and Safety of Nasal Herbal Steam Therapy for Post-extubation Respiratory Events : Pragmatic Randomized Controlled, Parallel Grouped Study
This study is testing if nasal steam therapy can help people feel better after having thyroid surgery and experiencing upper respiratory symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 19 Years to 69 Years |
| Sex | All |
| Sponsor | Ilsan Cha hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Goyang-si, Gyeonggi-do) |
| Trial ID | NCT06840106 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of nasal steam therapy compared to routine management for patients experiencing upper respiratory symptoms following endotracheal intubation during thyroid surgery. A total of 66 patients aged 19 to 69 will be randomly assigned to receive either nasal steam therapy or standard care for 5 days. The study aims to measure symptom improvement using the Wisconsin Upper Respiratory Symptom Survey. Treatment methods will be determined based on clinical judgment and recorded for analysis.
Who should consider this trial
Good fit: Ideal candidates are adults aged 19 to 69 who have undergone thyroid surgery with endotracheal intubation and developed upper respiratory symptoms.
Not a fit: Patients with chronic respiratory conditions or those who have had recent respiratory infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery and comfort for patients experiencing respiratory symptoms after thyroid surgery.
How similar studies have performed: While similar approaches have been explored, this specific application of nasal steam therapy in post-extubation patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age of 19 to 69 years
* Those who underwent surgical removal of the thyroid gland under endotracheal intubation due to a thyroid tumor
* American Society of Anesthesiologists (ASA) status I or II
* Those who developed upper respiratory symptoms after surgery ⑤ Voluntarily decided to participate in this clinical trial and signed the informed consent form
Exclusion criteria:
* Those diagnosed with symptomatic gastroesophageal reflux disease
* Chronic cough lasting for more than 3 months prior to surgery, including bronchial asthma and chronic obstructive pulmonary disease (COPD)
* Those who developed other respiratory infections within the past month ④ Those who are taking or are required to take other medications that may interfere with the interpretation of the treatment effect or results
* Those who are scheduled to undergo additional major treatments such as reoperation, chemotherapy, and radiotherapy during the clinical trial period ⑥ Pregnant women, breastfeeding women, and those who plan to become pregnant during the study period ⑦ Others who are expected to have difficulty complying with the treatment, visits, and questionnaires stipulated in this protocol at the discretion of the medical staff
Where this trial is running
Goyang-si, Gyeonggi-do
- Ilsan Cha Hospital — Goyang-si, Gyeonggi-do, South Korea (Recruiting)
Study contacts
- Study coordinator: Jee Young Lee, MD(KMD), PhD
- Email: happiade@chamc.co.kr
- Phone: 082-31-782-3113
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.